FINWIRES · TerminalLIVE
FINWIRES

Asia Biofuels Update: Malaysian Palm Oil Futures Ease on Negative Demand Sentiment

-- Malaysian palm oil futures were steady to lower on Wednesday, as a potential weakening in biofuels demand following a recent drop in crude oil prices weighed on sentiment.

The Bursa Malaysia Derivatives' May crude palm oil contract was flat at 4,420 Malaysian ringgit ($1,118.99) per metric ton in midday trade. The June contract slipped 0.13% to 4,460 ringgit/mt. Both contracts touched five-month lows earlier in the session.

"International crude oil prices are weakening, and the economic foundation for palm-oil producing countries to implement biofuel policies is being undermined," price reporting agency MySteel said.

To help ensure a stable supply of diesel, the Malaysian government on Tuesday reportedly agreed to increase its biodiesel mandate to 15% from the current 10%, with phased implementation to start with a 12% blend using existing biodiesel plants, according to multiple media outlets.

The country is currently mandating a 10% biodiesel blend for the transportation sector, and has introduced a 20% blend in few provinces.

Malaysia's move followed Indonesia's plan to raise its biodiesel mandate to 50% from the current 40% beginning July 1, and Thailand's decision to increase blending ratio to 7% from the current 5%.

Thailand has also tightened export controls for palm oil to boost domestic supply.

However, "Thailand's policy of restricting palm oil exports has already shown adverse effects, reflecting the possibility that expectations of tightening future palm oil supply may diminish as crude oil prices weaken," MySteel said.

In Malaysia, the reference price for palm oil was raised to $4,521.89 ringgit/mt in May from 3,935.19 ringgit/mt in April, despite recent declines in futures. Export duty correspondingly increased to 10% from 9.5%.

This could weigh on Malaysian export demand, which has so far shown a 30.7% to 38.9% month-over-month drop during the first 10 days of April, according to cargo surveyor estimates.

A possible increase in Indian purchases as buyers stock up ahead of seasonal demand could provide some upside.

Indian buyers reportedly cut their palm oil purchases last month due to high prices, with imports dropping to a three-month low of 689,462 metric tons in March, from 847,689 mt in February, according to the Solvent Extractors' Association of India.

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB